# Rifaximin Versus Placebo in the Prevention of Travelers' Diarrhea

> **NCT00098384** · PHASE2 · COMPLETED · sponsor: **DuPont, Hurbert L., MD** · enrollment: 220 (—)

## Conditions studied

- Diarrhea

## Interventions

- **DRUG:** rifaximin

## Key facts

- **NCT ID:** NCT00098384
- **Lead sponsor:** DuPont, Hurbert L., MD
- **Sponsor class:** INDIV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** —
- **Final completion:** 2003-09
- **Target enrollment:** 220 (—)
- **Last updated:** 2006-05-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00098384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00098384, "Rifaximin Versus Placebo in the Prevention of Travelers' Diarrhea". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00098384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*